![Vivani Medical Inc](/common/images/company/N_VANI.png)
Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need.
NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, with twice-yearly administration Study represents the first...
Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that CEO Adam...
Regulatory approval to initiate first-in-human study with a miniature, ultra long-acting GLP-1 (exenatide) implant in obese or overweight individuals in Australia Miniature, ultra long-acting...
Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that it will...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.862068965517 | 1.16 | 1.19 | 1.1203 | 106466 | 1.16867352 | CS |
4 | -0.04 | -3.30578512397 | 1.21 | 1.23 | 1.1203 | 87997 | 1.18711371 | CS |
12 | -0.14 | -10.6870229008 | 1.31 | 1.5 | 1.1203 | 123590 | 1.26148519 | CS |
26 | 0.01 | 0.862068965517 | 1.16 | 1.5 | 1.1 | 104388 | 1.26360481 | CS |
52 | 0.14 | 13.5922330097 | 1.03 | 7.8 | 1.01 | 933454 | 3.31347101 | CS |
156 | -3.03 | -72.1428571429 | 4.2 | 7.8 | 0.7536 | 411013 | 3.15784636 | CS |
260 | -3.03 | -72.1428571429 | 4.2 | 7.8 | 0.7536 | 411013 | 3.15784636 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales